首页> 外文期刊>Journal of synchrotron radiation >Comparison of in vitro breast cancer visibility in analyser-based computed tomography with histopathology, mammography, computed tomography and magnetic resonance imaging
【24h】

Comparison of in vitro breast cancer visibility in analyser-based computed tomography with histopathology, mammography, computed tomography and magnetic resonance imaging

机译:基于分析仪的计算机断层扫描与组织病理学,乳腺X线摄影,计算机断层扫描和磁共振成像中体外乳腺癌可见度的比较

获取原文
获取原文并翻译 | 示例
           

摘要

High-resolution analyser-based X-ray imaging computed tomography (HR ABI-CT) findings on in vitro human breast cancer are compared with histopathology, mammography, computed tomography (CT) and magnetic resonance imaging. The HR ABI-CT images provided significantly better low-contrast visibility compared with the standard radiological images. Fine cancer structures indistinguishable and superimposed in mammograms were seen, and could be matched with the histopathological results. The mean glandular dose was less than 1 mGy in mammography and 12-13 mGy in CT and ABI-CT. The excellent visibility of in vitro breast cancer suggests that HR ABI-CT may have a valuable role in the future as an adjunct or even alternative to current breast diagnostics, when radiation dose is further decreased, and compact synchrotron radiation sources become available.
机译:将基于高分辨率分析仪的X射线成像计算机断层扫描(HR ABI-CT)在体外人类乳腺癌中的发现与组织病理学,乳房X线照片,计算机断层扫描(CT)和磁共振成像相比较。与标准放射图像相比,HR ABI-CT图像可提供更好的低对比度可见度。可以看到在乳房X线照片中无法区分和重叠的精细癌症结构,并且可以与组织病理学结果相匹配。乳腺X线摄影的平均腺体剂量小于1 mGy,CT和ABI-CT的平均腺体剂量小于12-13 mGy。体外乳腺癌的出色可见性表明,当辐射剂量进一步降低并且紧凑型同步加速器辐射源可用时,HR ABI-CT在将来可能作为当前乳腺癌诊断的辅助手段甚至替代手段具有重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号